Obesity type 2 diabetes mellitus
Clinical trials for Obesity type 2 diabetes mellitus explained in plain language.
Never miss a new study
Get alerted when new Obesity type 2 diabetes mellitus trials appear
Sign up with your email to follow new studies for Obesity type 2 diabetes mellitus, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill aims to help people with diabetes shed pounds and control blood sugar
Disease control OngoingThis study tests a new daily pill, aleniglipron, in 58 adults with type 2 diabetes who are overweight or obese. The main goal is to check if the drug is safe and tolerable at different doses. Researchers will also measure weight loss and blood sugar changes. The study is not yet …
Matched conditions: OBESITY TYPE 2 DIABETES MELLITUS
Phase 2 • Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
App aims to boost nutrition for GLP-1 users
Knowledge-focused OngoingThis study tests a smartphone app designed to help adults taking GLP-1 medications for obesity or type 2 diabetes eat better. About 50 participants will use the app for 6 weeks to track their diet and learn about nutrition. The goal is to see if the app is helpful and easy to use…
Matched conditions: OBESITY TYPE 2 DIABETES MELLITUS
Sponsor: University of South Carolina • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
GLP-1 Users' diets under the microscope: what are they really eating?
Knowledge-focused OngoingThis study follows 50 adults who are about to start GLP-1 therapy for obesity or type 2 diabetes. Researchers will track how their eating habits change over 12 weeks using diet quality scores and body weight. The goal is to understand what dietary support people need while on the…
Matched conditions: OBESITY TYPE 2 DIABETES MELLITUS
Sponsor: University of South Carolina • Aim: Knowledge-focused
Last updated Jul 25, 2026 00:00 UTC